Company Filing History:
2 out of 1,743 
2 out of 11 
1 out of 124 
Years Active: 2023-2025
Title: Michel Treilhou: Innovator in Immunomodulatory Peptides
Introduction
Michel Treilhou is a notable inventor based in Lescure-d'Albigeois, France. He has made significant contributions to the field of immunology through his innovative work on peptides. With a total of 2 patents, Treilhou's research focuses on the development of immunomodulatory peptides that have potential applications in medical science.
Latest Patents
Treilhou's latest patents include an isolated peptide consisting of a sequence of 3 to 39 amino acids derived from the amino acid sequence SEQ ID NO: 1. This peptide has a sequence of amino acids selected from a specific group, which includes sequences that comprise at least the residues 6 to 8 of SEQ ID NO: 1. Additionally, the patent covers sequences that have at least 70% identity with the aforementioned sequence.
Career Highlights
Throughout his career, Michel Treilhou has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Rouen Normandie. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Treilhou has collaborated with notable colleagues, including Khaddouj Benmoussa and Elsa Bonnafe. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Michel Treilhou is a distinguished inventor whose work on immunomodulatory peptides has the potential to influence medical research significantly. His contributions to the field are marked by his patents and collaborations with leading institutions and colleagues.